Φορτώνει......

Directed Therapy for Patients with Myelodysplastic Syndromes (MDS) by Suppression of Cyclin D1 with ON 01910.Na

BACKGROUND: We previously demonstrated upregulation of c-myc, survivin, and cyclin D1 in CD34+ bone marrow mononuclear cells (BMMNCs) of patients with trisomy 8 and monosomy 7 myelodysplastic syndromes (MDS). “Knockdown” of cyclin D1 by RNA interference decreased trisomy 8 cell growth, suggesting th...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Olnes, Matthew J., Shenoy, Aarthie, Weinstein, Barbara, Pfannes, Loretta, Loeliger, Kelsey, Tucker, Zachary, Tian, Xin, Kwak, Minjung, Wilhelm, Francois, Yong, Agnes S.M., Maric, Irina, Maniar, Manoj, Scheinberg, Phillip, Groopman, Jerome, Young, Neal S., Sloand, Elaine M.
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	2012
Θέματα:	Article
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3381873/ https://ncbi.nlm.nih.gov/pubmed/22524974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2012.04.002
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Directed Therapy for Patients with Myelodysplastic Syndromes (MDS) by Suppression of Cyclin D1 with ON 01910.Na

Παρόμοια τεκμήρια